UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature (London), ISSN 0028-0836, 2016, Volume 538, Issue 7625, pp. 344 - 349
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Azabicyclo Compounds - pharmacology | Plasmodium falciparum - enzymology | Malaria, Falciparum - prevention & control | Male | Plasmodium falciparum - cytology | Azetidines - pharmacology | Plasmodium falciparum - drug effects | Cytosol - enzymology | Malaria, Falciparum - transmission | Liver - drug effects | Azabicyclo Compounds - chemical synthesis | Azabicyclo Compounds - therapeutic use | Female | Safety | Antimalarials - chemical synthesis | Disease Models, Animal | Life Cycle Stages - drug effects | Malaria, Falciparum - drug therapy | Azabicyclo Compounds - administration & dosage | Azetidines - adverse effects | Phenylurea Compounds - therapeutic use | Antimalarials - therapeutic use | Macaca mulatta - parasitology | Phenylalanine-tRNA Ligase - antagonists & inhibitors | Drug Discovery | Antimalarials - pharmacology | Animals | Azetidines - administration & dosage | Phenylurea Compounds - chemical synthesis | Antimalarials - administration & dosage | Azetidines - therapeutic use | Phenylurea Compounds - administration & dosage | Mice | Phenylurea Compounds - pharmacology | Liver - parasitology | Plasmodium falciparum - growth & development | Prevention | Antimalarials | Disease transmission | Health aspects | Transfer RNA | Proteins | Cytochrome | Malaria | Liver | Parasites | Kinases | Drug resistance | Drug dosages | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 2014, Volume 58, Issue 4, pp. 1835 - 1846
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Azabicyclo Compounds - pharmacology | Humans | Enzyme Inhibitors - pharmacology | Gram-Negative Bacterial Infections - drug therapy | Enzyme Inhibitors - therapeutic use | Gram-Negative Bacteria - enzymology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Drug Resistance, Multiple, Bacterial | Azabicyclo Compounds - therapeutic use | Anti-Bacterial Agents - pharmacology | beta-Lactamase Inhibitors | Index Medicus | Minireview
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 07/2007, Volume 82, Issue 1, pp. 21 - 32
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Analgesics - pharmacology | Muscarinic Agonists - pharmacology | Cholesterol - blood | Humans | Glycoproteins - pharmacology | Caproates - therapeutic use | Amines - therapeutic use | Alzheimer Disease - psychology | Neutrophil Infiltration - drug effects | United States Food and Drug Administration | Glycoproteins - therapeutic use | Alzheimer Disease - drug therapy | gamma-Aminobutyric Acid - pharmacology | Stroke - drug therapy | Cognition - drug effects | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Models, Biological | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Amines - pharmacology | Immunologic Factors - pharmacology | Clinical Trials as Topic - legislation & jurisprudence | Guidelines as Topic | Meta-Analysis as Topic | Clinical Trials as Topic - statistics & numerical data | United States | Caproates - pharmacology | Muscarinic Agonists - therapeutic use | Oximes - therapeutic use | Drug Approval | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Computer Simulation | Drug Design | gamma-Aminobutyric Acid - therapeutic use | Stroke - immunology | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Hypercholesterolemia - blood | Reproducibility of Results | Neuralgia, Postherpetic - drug therapy | Pharmacology | Models, Statistical | Animals | Anticholesteremic Agents - therapeutic use | Cyclohexanecarboxylic Acids - pharmacology | Oximes - pharmacology | Clinical Trials as Topic - methods | Pharmacokinetics | Research Design | Anticholesteremic Agents - pharmacology | Immunologic Factors - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 01/2019, Volume 68, Issue 3, pp. 519 - 524
carbapenem-resistant Enterobacteriaceae | ceftazidime/avibactam | Klebsiella pneumoniae carbapenemase | meropenem/vaborbactam | antimicrobial stewardship | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Carbapenem-Resistant Enterobacteriaceae - isolation & purification | Enterobacteriaceae Infections - microbiology | Humans | Boronic Acids - therapeutic use | Meropenem - therapeutic use | Anti-Bacterial Agents - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Heterocyclic Compounds, 1-Ring - therapeutic use | Azabicyclo Compounds - therapeutic use | Disease Management | Carbapenem-Resistant Enterobacteriaceae - drug effects | Ceftazidime - therapeutic use | Drug Combinations | Enterobacteriaceae Infections - drug therapy | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 11, pp. 1380 - 1389
phase 3 | complicated intra-abdominal infection | meropenem | ceftazidime-avibactam plus metronidazole | noninferiority | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Male | Young Adult | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Aged, 80 and over | Metronidazole - adverse effects | Adult | Azabicyclo Compounds - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Thienamycins - adverse effects | Azabicyclo Compounds - adverse effects | Thienamycins - therapeutic use | Thienamycins - administration & dosage | Azabicyclo Compounds - administration & dosage | Metronidazole - administration & dosage | Treatment Outcome | Intraabdominal Infections - epidemiology | Adolescent | Ceftazidime - administration & dosage | Aged | Ceftazidime - adverse effects | Anti-Bacterial Agents - administration & dosage | Intraabdominal Infections - drug therapy | Ceftazidime - therapeutic use | Usage | Care and treatment | Abscess | Clinical trials | Dosage and administration | Ceftazidime | Abdomen | Confidence intervals | Prescription drugs | Pathogens | Antibiotics | Index Medicus | and Commentaries
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6234 - 6243
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Imipenem - therapeutic use | Humans | Middle Aged | Cilastatin - pharmacokinetics | Male | Imipenem - pharmacokinetics | Young Adult | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Azabicyclo Compounds - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Cilastatin - therapeutic use | Azabicyclo Compounds - pharmacokinetics | Drug Therapy, Combination | Bacterial Infections - microbiology | Azabicyclo Compounds - adverse effects | Double-Blind Method | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Azabicyclo Compounds - administration & dosage | Treatment Outcome | Adolescent | Anti-Bacterial Agents - pharmacokinetics | Aged | Anti-Bacterial Agents - administration & dosage | Intraabdominal Infections - drug therapy | Drug Combinations | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | Index Medicus | and Commentaries
Journal Article
8.
Full Text
Pharmacological interventions for sleepiness and sleep disturbances caused by shift work
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 8, pp. CD009776 - CD009776
Wakefulness‐Promoting Agents | Melatonin | Piperazines | Benzhydryl Compounds | Mental health | 2. Management of occupational disease or symptoms | 1.1.3 Circadian rhythm disruption (e.g. shiftwork) | Randomized Controlled Trials as Topic | Sleep | Modafinil | Wakefulness | Sleep Disorders, Circadian Rhythm | Azabicyclo Compounds | Hypnotics and Sedatives | Managing occupational disease | Occupational health outcome | 1.1 Decreasing or eliminating harmful exposure to prevent occupational disease | Medicine General & Introductory Medical Sciences | 2.1.2 Mental and behavioural disorders | Caffeine | Health & safety at work | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Wakefulness-Promoting Agents - therapeutic use | Wakefulness - drug effects | Humans | Piperazines - therapeutic use | Hypnotics and Sedatives - therapeutic use | Sleep - drug effects | Sleep Disorders, Circadian Rhythm - drug therapy | Caffeine - therapeutic use | Melatonin - therapeutic use | Wakefulness - physiology | Azabicyclo Compounds - therapeutic use | Sleep - physiology | Benzhydryl Compounds - therapeutic use | Index Medicus
Journal Article